EE286 Cost Effectiveness and Public Health Impact of Implementing Gender-Neutral Vaccination with the 9-Valent Human Papillomavirus Vaccine in Turkiye

This study will assess the cost effectiveness and health impact of inclusion of Gender-Neutral Vaccination (GNV) with 9-Valent HPV (9vHPV) in NIP in Turkiye for individuals aged 11-12 years old.

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: B. Akyol Ersoy, E. Ko ç, A. Pavelyev, V. Daniels, D. Ugrekhelidze, S. Malhan, M. Basaran, E. Ozyar, G. Hafiz, P.F. Yumuk, U. Selek, T. Yalti, T. Esen, C. Taskiran, M. Gultekin, M.F. Kose, N. Ozgul Source Type: research